AKT anticorps (V-Akt Murine Thymoma Viral Oncogene Homolog 1) (N-Term)

Details for Product anti-AKT1 Antibody No. ABIN2707319
Antigène
Épitope
N-Term
94
45
36
36
27
24
24
24
21
20
19
18
13
13
13
12
12
11
11
10
10
10
10
9
9
8
7
7
7
7
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Singe, Souris, Rat
696
433
334
42
36
27
25
23
20
16
6
5
4
3
3
2
2
1
1
1
1
1
Hôte
Lapin
593
129
8
4
2
1
Clonalité
Polyclonal
Conjugué
Cet anticorp AKT est non-conjugé
44
27
26
23
19
17
15
15
15
15
14
14
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
Application
Immunohistochemistry (IHC), Western Blotting (WB)
574
339
335
119
101
85
83
44
34
25
16
13
12
10
7
6
3
3
2
1
1
1
1
1
1
Options
Immunogène KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human AKT.
Blocking Peptide Blocking peptide for this product available: ABIN2708724
Specificité Recognizes endogenous levels of AKT protein.
Attributs du produit Rabbit polyclonal antibody to AKT
Purification The antibody was purified by immunogen affinity chromatography.
Antigène
Autre désignation AKT (AKT1 Antibody Extrait)
Sujet PKB, RAC, RAC-alpha serine/threonine-protein kinase, Protein kinase B, PKB, Protein kinase B alpha, PKB alpha, Proto-oncogene c-Akt, RAC-PK-alpha
ID gène 207, 11651, 24185
UniProt P31749, P31750, P47196
Pathways Signalisation PI3K-Akt, Signalisation RTK, TCR Signaling, AMPK Signaling, Interferon-gamma Pathway, Signalisation TLR, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Water Deprivation, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Negative Regulation of intrinsic apoptotic Signaling, Thromboxane A2 Receptor Signaling, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGFR1 Specific Signals, VEGF Signaling
Indications d'application WB (1:500 - 1:1000), IH (1:100 - 1:200)
Restrictions For Research Use only
Format Liquid
Buffer Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock -20 °C
Stockage commentaire Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
Date de péremption 12 months
Images
Image no. 1 for anti-V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (N-Term) antibody (ABIN2707319) Immunohistochemical analysis of AKT staining in human brain formalin fixed paraffin e...
Image no. 2 for anti-V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (N-Term) antibody (ABIN2707319) Western blot analysis of AKT expression in HeLa (A), A549 (B), Raw264.7 (C), NIH3T3 (...